TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money April 24, 1987
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition June 14, 1996